Skip to main content
Equibles
MWAI logo

MWAI · MedWellAI, Inc. · Metrics

Track MWAI — free

Use MWAI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MWAI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.28 +0.04 (+17.02%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Oct 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Historically, the Company has reported recurring net losses from operations and used net cash in operating activities. As of June 30, 2026, the Company’s current liabilities exceeded its current assets by $7,847,263 and the Company had an accumulated deficit of $90,263,345. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.”
View the 10-K filed Oct 13, 2026
Market Cap
$1.83M
Shares
6.54M
Volume · Oct 21 1823 Avg daily vol (3M) 2845

MWAI metrics

54 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.28
Market cap
$1.83M

Price action

20 metrics
Price change (1W)
-12.0%
Price change (30D)
-24.4%
Price change (3M)
-24.0%
Price change (6M)
-24.4%
Price change (YTD)
-44.0%
Price change (1Y)
-59.3%
Trailing year
Price change (5Y)
—
52-week high
$0.77
52-week low
$0.20
Change from 52-week high
-63.4%
Change from 52-week low
+39.9%
Annualized volatility
213.7%
Annualized volatility (3M)
—
Beta
0.2
RSI (14D)
46.8
Price vs SMA 50
-7.9%
Price vs SMA 200
-40.3%
Avg volume (3M)
2,845
Relative volume
0.6
Average dollar volume
$825

Company

3 metrics
Sector
Financial Services
Industry
Capital Markets
Shares outstanding
6.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.5×
reciprocal yield 28.8%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-86.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-234.2%
Trailing 12 months
Net margin
-300.8%
Gross profit (TTM)
−$2.62M
Operating profit (TTM)
−$1.24M
Net income (TTM)
−$1.59M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.22

Growth

11 metrics
Revenue growth YoY
-533.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$527,857
Trailing 12 months
EPS growth YoY
-1,100.0%
Shares change YoY
-67.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-48.5%
Revenue CAGR (5Y)
-22.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-1,130.4%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-23.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$86,222
Total assets
$140,447
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$307,030
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$30
Stock compensation (TTM)
$223,018
R&D / revenue
—
Stock compensation / revenue
42.2%

Ownership (13F)

9 metrics
13F filers
16
13F filer change QoQ
+3
Institutional ownership
13.2%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.6 days to cover
Days to cover
1.6d
Short-squeeze score
23 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1520118 CUSIP 45826P309 Visit website